INTRODUCTION
Enterotoxigenic Bacteroides fragilis (ETBF) is an intestinal bacteria that has been associated with inflammatory bowel disease and colorectal cancer in humans (1, 2) . ETBF also cause diarrhea and colitis in both livestock and laboratory animals (3) (4) (5) (6) (7) . In the Min mouse model, ETBF promotes colonic tumorigenesis via the Th17/IL-23 pathway (8) . The only known virulence factor specific for ETBF is the secreted 20 kDa metalloprotease called B. fragilis toxin (BFT) (9, 10) . Addition of purified BFT to colonic epithelial cell lines induces several distinct changes. These include ectodomain cleavage of E-cadherin, morphological "rounding" of cells and secretion of IL-8 (11) (12) (13) (14) . E-cadherin is a 120 kDa type I transmembrane protein essential to the formation of intercellular adhesion of adjacent epithelial cells (15) . The cytoplasmic domain of E-cadherin is bound to β-catenin, which in turn associates with α-catenin and cytoskeletal actin (16) .
These associations result in formation of a stable epithelial monolayer which provides a protection barrier against infiltration of external insults. The loss of this epithelial integrity results in inflammatory disorders including colitis. BFT induces rapid cleavage of the extracellular domain of E-cadherin which result in cell rounding and loss of epithelial integrity. Subsequent E-cadherin degradation by γ-secretase releases the bound β-catenin and nuclear translocation of β-catenin activates the β-catenin-TCF-dependent pathway (17) .
To date, several cytokines and chemokines have been identified to be secreted in response to BFT treatment of intestinal epithelial cells: TGF-β, ENA-78, GRO-α, MCP-1 and IL-8 (13, 14, 18) . IL-8 is a potent inflammatory chemokine that is quickly secreted in response to microbial insults and functions to recruit neutrophils to sites of damage. IL-8 induction can occur through activation of the NF-κB and MAPK pathways. Using hepatoma cells, Levy et al. found that stimulation of the β-catenin pathway induces expression of IL-8 due to the presence of a unique consensus Tcf/Lef site that is critical for IL-8 activation by β-catenin (19) . Taken together, we propose a model for BFT-induced IL-8 secretion in which the enzymatically active BFT induces E-cadherin degradation, which results in release of the bound β-catenin that in turn translocate into the nucleus and actives IL-8 expression. In this study, we present data suggesting that activation of the β-catenin pathway in the colonic epithelial cell line by disruption of the E-cadherin junction is sufficient to induce IL-8 secretion.
MATERIALS AND METHODS

Cell culture and reagents
The human colonic epithelial cells line (HT29/C1) was originally obtained from Dr. Daniel Louvard, Institut Pasteur, Paris, France). HEK293/17 cells were purchased from ATCC. Cells were cultured in 10% FBS-DMEM containing gentamicin (100 ug/ml) and penicillin/streptomycin. All cell culture reagents were purchased from GIBCO BRL Life Technologies (Rockville, MD, USA). Cells were grown to subconfluent monolayers (∼70%) in 6-well plates. The cells were then washed with serum-free DMEM three times and then cultured with 3 ml of serum-free DMEM containing purified BFT (100 ng/ml), EDTA (Sigma-Aldrich, USA), NaCl (Sigma-Aldrich, USA), LiCl (Sigma-Aldrich, USA), DSS (MW 30,000∼45,000; MP Biochemicals, USA), 0.05% trypsin solution (Gibco, USA) or recombinant human IL-1β (50 ng/ml)(R&D Systems, USA) for 24 hr. To induce physical damage to cells, the subconfluent monolayer was scratched full length with a 1 ml pipette tip either 5 or 20 times.
IL-8 ELISA and Western blot analysis
For IL-8 ELISA, cell culture supernatants were harvested, clarified by centrifugation and stored at −20 o C until analyzed by an IL-8 ELISA kit (R&D Systems, USA). Western blot analysis was performed as previously described (4) . In brief, cells were washed two times with ice-cold PBS and lysed on ice for 15 min in RIPA buffer (Sigma-Aldrich, USA) containing protease inhibitors (Roche, USA). Clarified lysates were stored at −20 o C until analyzed by Western blot analysis using monoclonal antibodies against the extracellular domain of E-cadherin (H108, Santa Cruz Biotechnology, USA) or β-actin (Sigma-Aldrich, USA). Lysates were electrophoresed under reducing conditions on 12% SDS-PAGE gels and then transferred to 0.22-μm nitrocellulose membranes. Appropriate HRP-conjugated secondary antibodies and SuperSignal West Pico chemiluminescent substrates (Pierce, USA) were used to develop the bands on X-ray film.
Data analysis
Statistical analysis and graphic presentation were performed using GraphPad Prism 5. p-values were calculated using Anova. Values are shown as mean and standard error of mean (SEM). Data were collected from 3∼5 independent experiments. A p-value＜0.05 was considered statistically significant.
RESULTS AND DISCUSSION
As previously reported, BFT induces IL-8 secretion in the colonic epithelial cell line HT29/C1 which expresses E-cadherin (Fig. 1A) . The induction of IL-8 secretion is considered to be due to cleavage of E-cadherin which releases the intracellular bound β-catenin leading to IL-8 secretion. Cells that do not express E-cadherin such as HEK293/17 cells do not secrete IL-8 in response to BFT treatment although these cells do have the capacity to release potent levels of IL-8 in response to inflammatory cytokine stimulation such as IL-β (Fig. 1A) . These results as well as results from other studies suggest that induction of IL-8 by BFT requires E-cadherin cleavage (4) . If induction of IL-8 is due to disruption of the E-cadherin junction by BFT mediated cleavage of E-cadherin, then enzymatic cleavage of the E-cadherin ectodomain by other en- zymes should also induce IL-8. To test this hypothesis, HT29/C1 cells were treated with dilute trypsin for 24 hr and the supernatant assessed for IL-8 secretion by ELISA. We found that trypsin treated HT29/C1 cells showed a dramatic loss of the full length 120 kDa E-cadherin protein and become refractile indicating a loss of cell-to-cell contact (data not shown). In trypsin treated cells, IL-8 secretion was induced in a trypsin concentration dependent manner suggesting that E-cadherin cleavage resulted in IL-8 induction (Fig.  1B) . Physical damage of the cellular monolayer was insufficient to induce IL-8 secretion as scratching the subconfluent monolayers with a sterile pipette tip either 5 times or 20 times did not induce IL-8 secretion (Fig. 1B) .
The results from the BFT treatment and trypsin treatment strongly suggest that cleavage of E-cadherin is the underlying reason for IL-8 induction. Homophilic E-cadherin interactions between adjacent epithelial cells require the presence of calcium to mediate a stable interaction. Addition of the calcium-chelating EDTA is known to disrupt this interaction without inducing E-cadherin cleavage. We examined if disruption of the E-cadherin homophilic interaction was sufficient to induce IL-8 addition. HT29/C1 cells were treated with different doses of EDTA (0, 1, 2.5, 5 mM) for 24 hr and the secreted IL-8 examined by ELISA. We found an EDTA dose-dependent increase in IL-8 secretion (Fig. 2A) . The addition of EDTA did not change any noticeable changes in protein levels of the full length E-cadherin and no evidence of E-cadherin cleavage as determined by Western blot analysis (Fig. 2B) . Similarly, we found that physical damage of the HT29/C1 cell monolayer using a pipette tip did not induce E-cadherin cleavage (Fig. 2B) . These results suggest that disruption of E-cadherin interaction without E-cadherin cleavage is sufficient to induce IL-8 secretion.
The promoter of the IL-8 gene contains a binding site for the β-catenin/TCF complex (19) . This observation suggests that activation of the β-catenin pathway may be sufficient to induce IL-8 secretion in HT29/C1 cells. To determine if HT29/C1 cells can secrete IL-8 through activation of the β-catenin pathway, we treated HT29/C1 cells with LiCl which is known to stimulate the β-catenin pathway (19, 20) . HT29/ C1 cells were treated with different concentrations of LiCl for 24 hr and IL-8 secretion determined by ELISA. We found a LiCl dose-dependent increase in IL-8 secretion beginning at 10 mM which then peaked at 50 mM. At 100 mM LiCl, IL-8 secreted was completely inhibited to background levels suggesting an optimal dose of 50 mM (Fig. 3A) . Equal concentrations of NaCl served as a control for LiCl treatment which did not induce IL-8 secretion at all concentrations used (Fig.  3A) . Next, we conducted a time course experiment with LiCl by treating HT29/C1 cells with 50 mM LiCl for 2, 4, 6 or 8 hrs and measured IL-8 by ELISA. We found an increase in IL-8 secretion beginning at 2 hr post-treatment and thereafter gradually increased over time (Fig. 3B) . These results suggest that activation of the β-catenin pathway is sufficient to induce IL-8 secretion in the HT29/C1 cell line.
ETBF has been suggested to contribute to development of colon cancers (8) . Considering that IL-8 expression correlates with induction and progression of colorectal cancer, it would be important to understand the precise mechanism by which BFT induces IL-8 secretion (21) . Taken together, our results suggest that in the HT29/C1 cell line, BFT induces IL-8 secretion by disruption of E-cadherin junctions and changes in cellular contacts which then lead to activation of the β-catenin pathway. BFT is known to induce E-cadherin cleavage and IL-8 secretion. However, it is not clear if E-cadherin cleavage is required for IL-8 secretion. Our data, raise the possibility that E-cadherin disruption and therefore cell-cell dissociation is sufficient to induce IL-8 secretion. We suggest that E-cadherin cleavage per se may not be required for BFT induced IL-8 secretion.
